Embera picks up $2 mln
Embera NeuroTherapeutics Inc, a biopharmaceutical company focused on treating addictions such as smoking and cocaine abuse, has secured $2 million in Series A-2 funding. The investors included HRA Pharma.
10 April 2015•3 mins read
